MetLife Probability of Target Price Finishing Over 57.78

MET -- USA Stock  

USD 43.83  0.83  1.86%

MetLife probability of target price tool provides mechanism to make assumptions about upside and downside potential of MetLife performance during a given time horizon utilizing its historical volatility. Please specify MetLife time horizon, a valid symbol (red box) and a target price (blue box) you would like MetLife odds to be computed. Please see also MetLife Backtesting, MetLife Valuation, MetLife Correlation, MetLife Hype Analysis, MetLife Volatility, MetLife History as well as MetLife Performance.
Horizon     30 Days    Login   to change
Symbol:
Refresh Odds

MetLife Target Price Odds to finish over 57.78

Current PriceHorizonTarget PriceOdds to move over $ 57.78  or more in 30 days
 43.83 30 days 57.78  NEAR 1%
Based on normal probability distribution, the odds of MetLife to move over $ 57.78  or more in 30 days from now is near 1% (This MetLife probability density function shows the probability of MetLife Stock to fall within a particular range of prices over 30 days) . Probability of MetLife price to stay between its current price of $ 43.83  and $ 57.78  at the end of the 30-day period is more than 93.0%.
Considering 30-days investment horizon, MetLife has beta of 0.499 indicating as returns on market go up, MetLife average returns are expected to increase less than the benchmark. However during bear market, the loss on holding MetLife will be expected to be much smaller as well. Additionally MetLife has a negative alpha implying that the risk taken by holding this equity is not justified. The company is significantly underperforming DOW
 MetLife Price Density 
 
      
Current Price   Target Price   
α
Alpha over DOW
=0.14
β
Beta against DOW=0.50
σ
Overall volatility
=1.79
Ir
Information ratio =0.04

MetLife Alerts

MetLife Alerts and Suggestions

MetLife generates negative expected return over the last 30 days
MetLife has high likelihood to experience some financial distress in the next 2 years
MetLife has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
About 82.0% of the company outstanding shares are owned by corporate insiders
Latest headline from www.fairfieldcurrent.com: Acquisition by Catherine Kinney of 802 shares of MetLife subject to Rule 16b-3

Price Density Drivers

MetLife Health Indicators

Shares Percent Shares Out1.34%
Trailing Annual Dividend Rate1.62
Short Percent Of Float1.55%
Float Shares842.59M
Shares Short Prior Month14.07M
Average Daily Volume Last 10 Day6.54M
Average Daily Volume In Three Month5.18M
Date Short InterestSeptember 28, 2018
Trailing Annual Dividend Yield3.70%
Please see also MetLife Backtesting, MetLife Valuation, MetLife Correlation, MetLife Hype Analysis, MetLife Volatility, MetLife History as well as MetLife Performance. Please also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Search macroaxis.com